Recurrent Pleural Malignant Mesothelioma
5 clinical trials · Condition
◉ Watch Recurrent Pleural Malignant Mesothelioma
| Record | Firm | Date |
|---|---|---|
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors (NCT03074513) | M.D. Anderson Cancer Center | 2017-03-03 |
| Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent (NCT02568449) | Barbara Ann Karmanos Cancer Institute | 2016-03-15 |
| Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin (NCT02535312) | National Cancer Institute (NCI) | 2016-03-08 |
| Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma (NCT02408016) | Fred Hutchinson Cancer Center | 2015-05-22 |
| Pembrolizumab in Treating Patients With Malignant Mesothelioma (NCT02399371) | University of Chicago | 2015-03-31 |
Track Recurrent Pleural Malignant Mesothelioma automatically
Every clearance here is in the API, with alerts when new ones post.